FDA 2021년 12월 04일 13시 27분 ​ FDA=＞화이자 약품에 심각한 사망 위험 경고

[최성식(경남진해)]

속 보 _ 2021년 12월 04일 13시 27분

화이자 약품에 심각한 사망 위험 경고

코로나 백신 사기극의 대장급인 화이자에 대한 수사가 시작되자 그 동안 화이자랑 짝짝쿵 하며 공범 노릇하던 미국 식품의약국 FDA가 갑자기 화이자에 엄중한 경고를 하고 나섰는데요...

The FDA has recently admitted there is now major concern over another Pfizer product. It is now slapping a warning on a class of anti-inflammatory treatments called JAK inhibitors.

“The U.S. health regulator has added its strictest warning to the labels of drugs from Pfizer, Eli Lilly and AbbVie belonging to a class of anti-inflammatory treatments called JAK inhibitors, citing risk of serious health issues and death in patients 50 and over,” Reuters reported on Friday, citing the drug manufacturers.

“The addition of the warning on the labels follows the agency’s review of Pfizer’s Xeljanz after initial results from a February trial showed an increased risk of serious heart-related problems and cancer in some patients being treated with the drug,” the report added.

The alarming development is a reminder of the rushed approval of Pfizer’s “vaccine.” In June, the COVID-19 Vaccine Safety Technical (VaST) Work Group noted the adverse reaction in vaccinated males between the ages of 16 and 24. The development of the heart condition was observed in adolescents and young adults and was considerably higher after the second dose in males.

Rep. Thomas Massie noted that the Expected and Observed categories in VAERS diverged dramatically for Myocarditis and Pericarditis in the age groups ranging from 12 to 49.

A retired cardiac surgeon recently circulated a warning to the AHA that heart inflammation markers are drastically increasing in patients in conjunction with increasing mRNA Covid vaccination rates.

The warning to the AHA is clear: “Patients had a 1 in 4 risk for severe problems after the vaccines, compared to 1 in 9 before.”

The controversial memo, which is a call for further research, has drawn a backlash among outlets attempting to control the narrative. But it has more corroboration than the mainstream media lets on.

An NIH-hosted scientific publication explored the potential relationship between the mRNA ‘vaccines’ and heart inflammation reports in July 2021.

“As of 26 June 2021, a total of 322 million doses of vaccine were used, and thus far, 79 children aged 16 or 17 years, and 196 young adults aged 18–24 years have been confirmed by the CDC as having myocarditis/pericarditis following mRNA COVID-19 vaccination after analyzing data in the VAERS,” the paper points out.

“The adjusted risk ratio for myocarditis and pericarditis events in children and young adults between 16 and 24 years of age has been determined to be 0.94 (95% confidence interval 0.59–1.52). Because of this, the US FDA added a warning about risk of myopericarditis and pericarditis to the fact sheet of mRNA COVID-19 vaccines.”

“Recently, the US military reported 23 patients among 2.8 million doses of mRNA COVID-19 vaccine administered,” the paper continues. “While the observed number of myocarditis cases was small, the number was higher than expected among male military members after a second vaccine dose.”

“In a report from the Israeli Ministry of Health, one in 3000 to one in 6000 men aged 16–24 who received the mRNA COVID vaccine developed myocarditis and pericarditis,” it added. “Ninety percent of the cases in Israel appear to be men. Although the background rate of myocarditis in this population is high, the rate following vaccination appeared to be 5–25 times higher than the background rate.”

“The European Medicines Agency has also recently reported that myocarditis and pericarditis can occur in very rare cases following vaccination with COVID-19 vaccines Comirnaty [Pfizer-BioNTech] and Spikevax [Moderna].

“The Committee is therefore recommending listing myocarditis and pericarditis as new side effects in the product information for these vaccines, together with a warning to raise awareness among healthcare professionals and people taking these vaccines,” the article notes. “The European Medicine Agency’s safety committee (PRAC) has included 145 cases of myocarditis in the European Economic Area (EEA) among people who received Comirnaty and 19 cases following the use of Spikevax. As of 31 May 2021, around 177 million doses of Comirnaty and 20 million doses of Spikevax had been given in the EEA. As of end of May 2021, the incidence of myocarditis is 1 per million for both Comirnaty and Spikevax in the EEA.”

The data therefore call into question whether or not the CDC and FDA are being straight with the American people about the actual side effects, even as it has recommended that children as young as 5 years old get the shots. Indeed, President Biden has promised he will do everything in his power to make sure even children under 5 years old get the mRNA shots.

In 2009, Pfizer paid out a massive settlement over its fraudulent marketing of a drug.

“The pharmaceutical giant Pfizer agreed to pay $2.3 billion to settle civil and criminal allegations that it had illegally marketed its painkiller Bextra, which has been withdrawn,” the New York Times reported.

“It was the largest health care fraud settlement and the largest criminal fine of any kind ever,” the Times noted.

[이시윤(경기용인)]

어이구 뭔일이래요.
근데 왜 뉴스에 안 나오는 거죠?

[최성식(경남진해)]

잠깐만요,,,번역에 문제가 있어 보입니다. 다시 찾아보고 올려보도록 하겠습니다.

[최성식(경남진해)]

여기 의사 선생님들한테 여쭤봐야 알 수 있을 것 같습니다. JAK inhibitors 가 covid 19 백신에 포함되어 있는 약물인지 아닌지...말이죠..?? 화이자, 소염제 들어 있는 Xeljanz 라는 관절염 arthritis 약도 50대 이상에서 헬스 이슈와 사망을 일으킨다는...구글링 해보니 JAK inhibitors가 SARS Cov 때부터 치료제와 백신 속에서 어떤 연관 약물인 것 같습니다. 그렇다면, 위 기사도 아얘 틀린 말도 아니라는게 됩니다. 아니라면, 다른 사이트의 다른 분 댓글처럼, 무슨 신뢰도를 떨어뜨린다는 얘기가 되어서 저도 부지런히 찾아보고 있습니다. 소아랑 tv 자료를 더 많이 보고 와야 겠습니다. 거기에 백신 자료가 더 있는 것 같습니다.

[최성식(경남진해)]

아래 그림을 보면 JAK 억제제가 싸이토카인 후폭풍을 막는 역할을 기대하는 것 같습니다. 다른 기사를 찾아 보니 이미 9월 부터 화이자의 이 약물이 다른 회사의 것보다 심장 위험이 더 높아서 라벨 표시를 더 강화하는 요구가 있어왔던 중인가봅니다.

https://www.pharmstoday.com/news/articleView.html?idxno=309676 (메디팜스- JAK 억제제, 암‧심장 문제 안전성 경고(2021.9.2)

[최성식(경남진해)]

메디팜스투데이에는 이런 기사도 있습니다. 의료인연합 취지와는 다른 기사이고 코로나 배신은 안전하지 않다는 양심선언하고 다르니 분별해서 읽으셔야 합니다. 저도 의학지식 정보가 딸리는 소시민에 불과합니다. 위양성 기사가 많이 안보이고 안들리다 보니, PCR 검사가 pooling 검사로 20명씩 섞어서 검사한다는 것도 늦게 알았습니다. (질본에서는 정은경 본부장과 대한진단검사의학회 권계철 이사장은 “취합검사법은 코로나19 확인 검사로는 사용되지 않고, 증상이 없는 감염위험군의 질병감시 목적으로만 사용되므로, 환자진료 정확성을 걱정할 필요는 없다”고 언급하면서,“드러나지 않은 지역사회 환자발견으로 질병예방에 더욱 기여하게 될 것”이라고 덧붙였다.) 그러나 검사수 증가로 확진자수가 높아진다면, 속사정이 어떨지 다른 해명을 질본에 요구해야 될 것 같습니다.


http://www.pharmstoday.com/news/articleView.html?idxno=311717 -화이자‧모더나 코로나19 백신 최상의 보호 제공

[김지훈(울산)]

혹시 링크알수있을까요? 이게 진짜면 왜 이슈화안되는지.. ㅠㅠ